Is SS Innovations International Inc. Common Stock (SSII) overvalued? · rev $20.6M
SS Innovations International Inc. Common Stock (SSII) is a medical devices company listed on NASDAQ.
This page asks whether SS Innovations International Inc. Common Stock (SSII) looks expensive on cached numbers — not a short thesis.
Latest reported SSII revenue for 2024-12-31 was $20.6M. Net income was -$19.2M. Revenue was up 251.5% from 2023-12-31 to 2024-12-31. SSII currently screens at market cap $658.4M.
SSII currently screens at market cap $658.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SSII 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SSII stock page for the full model, not this heading.
Not investment advice.